Federal Register / Vol. 85, No. 247 / Wednesday, December 23, 2020 / Notices 83963 

exposed in the incident. Part III requires 

SkyMed to establish and implement, 

and thereafter maintain, a 

comprehensive information security 

program that protects the security, 

confidentiality, and integrity of 

consumers’ personal information. 

Part IV requires SkyMed to obtain 

initial and biennial data security 

assessments for twenty years. Part V of 

the Proposed Order requires SkyMed to 

disclose all material facts to the assessor 

and prohibits SkyMed from 

misrepresenting any fact material to the 

assessments required by Part IV. 

Part VI requires SkyMed to submit an 

annual certification from a senior 

corporate manager (or senior officer 

responsible for its information security 

program) that SkyMed has implemented 

the requirements of the Order and is not 

aware of any material noncompliance 

that has not been corrected or disclosed 

to the Commission. Part VII requires 

SkyMed to notify the Commission any 

time (1) it is required to make a 

notification to a federal, state, or local 

government that personal information 

has been breached or disclosed, or (2) 

individually identifiable health 

information from or about a consumer 

was, or is reasonably believed to have 

been, accessed, acquired, or publicly 

exposed without authorization. 

Parts VIII through XI are reporting and 

compliance provisions, which include 

recordkeeping requirements and 

provisions requiring SkyMed to provide 

information or documents necessary for 

the Commission to monitor compliance. 

Part XII states that the Proposed Order 

will remain in effect for twenty years, 

with certain exceptions. 

The purpose of this analysis is to aid 

public comment on the Proposed Order. 

It is not intended to constitute an 

official interpretation of the complaint 

or Proposed Order, or to modify in any 

way the Proposed Order’s terms. 

By direction of the Commission. 

April J. Tabor, 

Acting Secretary. 

[FR Doc. 2020–28262 Filed 12–22–20; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Advisory 

Committee on Breast Cancer in Young 

Women (ACBCYW) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

ACBCYW. The ACBCYW consists of 15 

experts in fields associated with breast 

cancer, disease prevention, early 

detection, diagnosis, public health, 

social marketing, genetic screening and 

counseling, treatment, rehabilitation, 

palliative care, and survivorship in 

young women, or in related disciplines 

with a specific focus on young women. 

DATES: Nominations for membership on 

the ACBCYW must be received no later 

than March 12, 2021. Packages received 

after this time will not be considered for 

the current membership cycle. 

ADDRESSES: All nominations should be 

mailed to Jeremy McCallister, c/o 

ACBCYW Secretariat, Centers for 

Disease Control and Prevention, 3719 

North Peachtree Road, Building 100 

Chamblee, Georgia 30341, or emailed 

(recommended) to acbcyw@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Jeremy McCallister, Designated Federal 

Officer, National Center for Chronic 

Disease Prevention and Health 

Promotion, CDC, 4770 Buford Highway 

NE, Mailstop F–76, Atlanta, Georgia 

30341, Telephone: 404–639–7989; 

Email: acbcyw@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishments of the committee’s 

objectives. Nominees will be selected 

based on expertise in the fields of breast 

health, breast cancer, disease prevention 

and risk reduction, survivorship 

(including metastatic breast cancer), 

hereditary breast and ovarian cancer 

(HBOC), or in related disciplines with a 

specific focus on young women. Persons 

with personal experience with early 

onset breast cancer are also eligible to 

apply. This includes but may not be 

limited to breast cancer survivors <45 

years of age and caregivers of said 

persons. Federal employees will not be 

considered for membership. Members 

may be invited to serve up to four-year 

terms. Election of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of ACBCYW 

objectives (https://www.cdc.gov/faca/ 

committees/acbcyw.html). 

The U.S. Department of Health and 

Human Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented, and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens, 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees, requiring the filing of 

financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for ACBCYW membership each year and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in November 2021, 

or as soon as the HHS selection process 

is completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. 

Nominees must be U.S. citizens, and 

cannot be full-time employees of the 

U.S. Government. Candidates should 

submit the following items: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address) 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

(Candidates may submit letter(s) from 

current HHS employees if they wish, 

but at least one letter must be submitted 

by a person not employed by an HHS 

agency (e.g., CDC, NIH, FDA, etc.). 

Nominations may be submitted by the 

candidate him- or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2020–28380 Filed 12–22–20; 8:45 am] 

BILLING CODE 4163–18–P 


jbell on DSKJLSW7X2PROD with NOTICES